OUR LATEST UPDATE: Biocoat Acquires Chempilots to Expand its Biomaterial Platform… READ MORE
OUR LATEST UPDATE: Biocoat Acquires Chempilots to Expand its Biomaterial Platform… READ MORE
Our hydrophilic coatings provide best-in-class performance with the industry’s lowest particulate counts. Our flexible service model allows you to coat your materials at your production facility or our Contract Coating Services Unit. Your medical device is specifically designed to achieve its intended goal, and our coatings allow your device to be easily maneuverable and highly durable to optimize vascular access and minimize procedure time.
At Biocoat, we are focused on researching, developing, manufacturing, and applying the best coatings in the market. Our team is fully dedicated to providing our customers with a best-in–class experience at every step.
Our R&D team is focused on developing coatings that best solve the needs of a constantly changing market.
Our team of coating experts is available to quickly test the performance of our coatings on your device.
Our flexible business model is here to support you if you coat at your facility or in our contract coating unit.
Our EMERSE Dip Coating System comes in multiple sizes to match your coating needs and desired throughput.
Our coatings can be applied to almost all polymerics. if you do not see your substrate listed below, please reach out.
Biocoat HYDAK technology allows for the coating of hydrophilic films used in medical devices. This capability allows for the processing of:
To support the development of cutting-edge medical devices, Biocoat has added dedicated in-house plasma capabilities. The use of plasma treatment supports the coating process by:
At Biocoat, our HYDAK coatings offer best-in-class performance in lubricity, durability, and particulates. Our coatings give you a choice to cure the coatings using either Thermal heat or Ultraviolet (UV) light. The following charts show the results of a series of tests that the Biocoat Research & Development team completed to test the friction, durability, and particulates on commercially available microcatheters to see how our coatings perform compared to other coatings on the market.
In this chart, the Biocoat R&D team purchased six (6) different commercially available angioplasty catheters, one (1) coated with Biocoat’s HYDAK® Thermal technology. The chart. The chart also shows Biocoat’s HYDAK® UV coating performance compared to the six (6) commercially available microcatheters. Biocoat team measured both the lubricity and durability of each catheter to determine where HYDAK® stands in relation to industry competitors. Our testing proves that HYDAK® exhibits best-in class lubricity and durability results
In this chart, the Biocoat R&D team tested six (6) commercially available 510K cleared devices. The Biocoat team measured particulate counts of our Biocoat HYDAK® UV and Thermal coatings to compare them in relation to industry competitors. The results show that the Biocoat UV and Thermal coatings provide significantly lower particle counts than the competition
To successfully complete the project design, the developing company’s engineering team required a l1igh performing hydrophilic coating and to implement production techniques to match the high volume and high efficiency production requirements during the introduction of a family of balloon catheters.
Biocoat was asked to develop a coating that would perform on each catheter being planned for the product portfolio. Each catheter had different coating requirements, including different coating lengths, lubricity requirements, masking and performance standards. One particularly challenging area was the development of a solution and process to mask the balloons on the catheters so that the coating did not interfere with the performance of the balloon.
Biocoat worked closely with the engineering team on each project to develop a coating to maximize the overall device performance. Biocoat also designed and assisted with developing production techniques that would allow for large volumes of product to be coated efficiently and effectively. Each product has been US-FDA approved and is available in several countries including the United States, Middle East, the Asia-Pacific region, Australia, Latin America, and Africa.
Michael Wallace 
CEO Devoro MedicalOur team of engineers and coating experts would be glad to have a discussion about your project and its requirements.
The latest news, articles, and resources, sent to your inbox.
